Johnson & Johnson (JNJ) Other Non Operating Income (2016 - 2025)
Johnson & Johnson's Other Non Operating Income history spans 17 years, with the latest figure at -$483.0 million for Q4 2025.
- For Q4 2025, Other Non Operating Income fell 400.0% year-over-year to -$483.0 million; the TTM value through Dec 2025 reached $7.2 billion, up 253.58%, while the annual FY2025 figure was $7.2 billion, 253.58% up from the prior year.
- Other Non Operating Income for Q4 2025 was -$483.0 million at Johnson & Johnson, down from $478.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $7.3 billion in Q1 2025 and bottomed at -$6.9 billion in Q2 2023.
- The 5-year median for Other Non Operating Income is -$249.5 million (2022), against an average of -$384.0 million.
- The largest annual shift saw Other Non Operating Income skyrocketed 2133.33% in 2021 before it plummeted 6903.92% in 2023.
- A 5-year view of Other Non Operating Income shows it stood at -$1.8 billion in 2021, then skyrocketed by 87.78% to -$226.0 million in 2022, then soared by 286.28% to $421.0 million in 2023, then crashed by 61.76% to $161.0 million in 2024, then plummeted by 400.0% to -$483.0 million in 2025.
- Per Business Quant, the three most recent readings for JNJ's Other Non Operating Income are -$483.0 million (Q4 2025), $478.0 million (Q3 2025), and -$107.0 million (Q2 2025).